Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05025813 |
| Title | Neoadjuvant Pembrolizumab in Cutaneous Squamous Cell Carcinoma (DESQUAMATE) |
| Acronym | DESQUAMATE |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Queensland Health |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Chris O'Brien Lifehouse | RECRUITING | Camperdown | New South Wales | 2050 | Australia | Details |
| Royal Brisbane and Women's Hospital | RECRUITING | Herston | Queensland | 4029 | Australia | Details |
| Princess Alexandra Hospital | RECRUITING | Woolloongabba | Queensland | 4102 | Australia | Details |